REFERENCES
- Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. J Cancer 1972;26:239–57.
- Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3–15.
- Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456–62.
- Arai T, Kida Y, Harmon BV, Gobe GC. Comparative alterations in p53 expression and apoptosis in the irradiated rat small and large intestine. Br J Cancer 1996;74:406–12.
- Moss SF, Attia L, Scholes JV, Walters JRF, Holt PR. Increased small intestinal apoptosis in coeliac disease. Gut 1996;39:811–7.
- Watson AJM. Necrosis and apoptosis in the gastrointestinal tract. Gut 1995;37:165–7.
- Que FG, Gores GJ. Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology 1996;110:1238–43.
- Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566–81.
- Sanderson IR, Walker WA. Uptake and transport of macromolecule by the intestine. Possible role in clinical disorders. Gastroenterology 1993;104:622–39.
- Thakkar NS, Potten CS. Inhibition of doxorubicin-induced apoptosis in vivo by 2-deoxy-d-glucose. Cancer Res 1993;53:2057–60.
- Kubes P. Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol 1993;264:G143–9.
- Kubes P, Ibbotson G, Russell JB, Wallace JL, Granger DN. Role of platelet-activating factor in reperfusion-induced leukocyte adherence. Am J Physiol 1990;258:G300–5.
- Gavrieli Y, Sherman Y, BenSasson SA. Identification of programmed death via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992;119:493–501.
- Shu S, Ju G, Fan L. The glucose oxidase-DAB-nickle method in peroxidase histochemistry of the nervous system. Neurosci Lett 1988;85:169–71.
- Bedi A, Pasricha PJ, Akhtar AJ, Barber GC, Gliardiello FM, Giardiello FM, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995;55:1811–6.
- Thakkar NS, Potten CS. Abrogation of adriamycin toxicity in vivo by cycloheximide. Biochem Pharmacol 1992;43:1683–91.
- Holm B, Jensen PB, Sehested M, Hansen HH. In vivo inhibition of etoposide-mediated apoptosis, toxicity, and antitumor effect by the topoisomerase II-uncoupling anthracycline aclarubicin. Cancer Chemother Pharmacol 1994;34:503–8.
- Tewey KM, Rowe TC, Young L, Halligan BD, Liu LF. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 1984;266:466–8.
- Chow KC, King CK, Ross WE. Abrogation of etoposide- mediated cytotoxicity by cycloheximide. Biochem Pharmacol 1988;37:1117–22.
- Lee FD. Importance of apoptosis in the histopathology of drug related lesions in the small intestine. J Clin Pathol 1993;46:118–22.
- Mansi J, Ellis E, Viner C, Mundy J, Millar J, Milan S, et al. Gut protection by cyclophosphamide ‘priming’ in patients receiving high-dose melphalan-effect of drug scheduling. Cancer Chemother Pharmacol 1992;30:149–51.